Pharmacokinetics, metabolism and clinical effect of ifosfamide in breast cancer patients

This publication has 24 references indexed in Scilit:

• Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide
  Biochemical Pharmacology, 1994
• A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma
  Cancer, 1991
• Epidoxorubicin plus ifosfamide in advanced and/or metastatic soft-tissue sarcomas
  Cancer Chemotherapy and Pharmacology, 1990
• Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer
  Cancer, 1990
• The effect of route of administration and fractionation of dose on the metabolism of ifosfamide
  Cancer Chemotherapy and Pharmacology, 1990
• Toxicity and response to high-dose ifosfamide+mesna as salvage therapy for advanced breast cancer
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1988
• Ifosamide
  JNCI Journal of the National Cancer Institute, 1988
• Metabolism of oxazaphosphorines
  Pharmacology & Therapeutics, 1988
• Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.
  Journal of Clinical Oncology, 1986
• Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)
  European Journal of Cancer and Clinical Oncology, 1982